# Commonly mutated gene could be a therapeutic target in sarcoma

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-commonly-mutated-gene-therapeutic-sarcoma.html) · 2026-11-19 · Medicine
Page: https://themorning.science/story/commonly-mutated-gene-could-be-a-therapeutic-target-in-sarcoma-d4e71d2d205043df
Kind: research · Impact: medium

## In brief

- Researchers at MD Anderson Cancer Center report that sarcomas lacking the ATRX gene tend to be more aggressive.
- Such sarcomas may be particularly vulnerable to TEAD inhibitors, a class of targeted therapies.

## Why it matters

ATRX loss may help identify sarcoma patients who could respond to TEAD inhibitors, pointing to a possible targeted treatment approach for a commonly mutated gene.

## Coverage

- [Commonly mutated gene could be a therapeutic target in sarcoma](https://medicalxpress.com/news/2026-11-commonly-mutated-gene-therapeutic-sarcoma.html) — Medical Xpress - latest medical and health news stories, 2026-11-19

Tags: sarcoma, atrx, cancer, targeted therapy, tead inhibitors

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
